Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
9 Reasons Why The Race For Major COVID-19 Vaccine Revenues Has Greatly Narrowed
10:06am, Wednesday, 02'nd Sep 2020
The huge amount of Operation Warp Speed funding for its six vaccines has helped them become somewhat dominant leaders in the race for a sizable share of the market.
Better Coronavirus Stock: Inovio Pharmaceuticals or Novavax?
06:37am, Wednesday, 02'nd Sep 2020
One of these high-flying biotechs is set up to stand out over the long-term.
Competitive Advantages Of Inovio's COVID Vaccine Makes Current Low Price A Buying Opportunity
03:49pm, Tuesday, 01'st Sep 2020
Inovio's COVID-19 vaccine race is not run.
Why Inovio Stock Slipped Today
03:39pm, Tuesday, 01'st Sep 2020
The more important question is: Why have Inovio's shares fallen for several weeks now?
Novavax: COVID-19 Gave It Fuel, But It's Running Near Empty
02:15pm, Monday, 31'st Aug 2020
NVAX had run over 4,000% YTD at its peak. COVID-19 vaccine hype is giving it some much-needed fuel after failing two late-stage clinical trials in 2016 and 2019.
Is The Party Over for Inovio Stock? It Depends
01:55pm, Monday, 31'st Aug 2020
Nevertheless, while it's not out of the running just yet, it may be best not to take a gamble with INO stock. Sit on the sidelines for now, and wait for a more compelling entry point.
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FT
12:47am, Monday, 31'st Aug 2020
The United States Food and Drug Administration is willing to expedite the COVID-19 vaccine authorization process, including granting emergency use authorization to a candidate before it completes lat
Has The COVID-19 Vaccine Stock Bubble Burst?
12:41pm, Sunday, 30'th Aug 2020
COVID-19 vaccine stocks have gotten slammed this month.
Are These the 3 Best Coronavirus Stocks to Buy Now?
08:08am, Saturday, 29'th Aug 2020
Looking at clinical trial data and other key elements offers us the answer.
How Moderna Will Fare After Posting Strong Clinical Results
03:37am, Friday, 28'th Aug 2020
Moderna posted strong clinical results that failed to lift shares. Phase 3 results will follow over the next two years.
3 Reasons You Should Still Keep an Eye on Inovio Pharmaceuticals
08:25am, Thursday, 27'th Aug 2020
INO stock is dropping on news that its Covid-19 vaccine candidate is falling behind more established candidates. But science says there may still be a chance.
1 Key Thing You Might Be Overlooking With Inovio
06:08am, Thursday, 27'th Aug 2020
The biotech's coronavirus vaccine candidate gets the spotlight, but you might want to shine some light on this program, too.
Inovio Shares Have Been Hot in 2020 but Watch for a Volatile September
05:16am, Thursday, 27'th Aug 2020
Although Inovio shares have skyrocketed this year as part of the vaccine development efforts, the momentum in INO stock may not not be strong.
The post Inovio Shares Have Been Hot in 2020 but Watch f
Thinking of Buying Inovio Stock? Here's What You Need to Know
07:34am, Wednesday, 26'th Aug 2020
The pharmaceutical company remains a step behind coronavirus vaccine leaders -- in funding and in the clinical trial timeline.
Inovio: A Viable Short, Falling Behind The Leaders In COVID-19 Vaccine Development
03:08pm, Tuesday, 25'th Aug 2020
INO is up over 300% year-to-date despite the recent sell off. INO-4800 got out of the blocks quickly, but the pace of development has faded a little.
